Search Results 351-360 of 11144 for ANCA vasculitis

  1. Cell Therapy Clinical Trials

    ... (ANCA) associated vasculitis using primary samples and/or patient derived xenograft models. A Study to Analyze AVB-114 to Treat Complex Crohn's Perianal ...

  2. Cardiovascular Medicine - Doctors - Mayo Clinic

    Anca Chiriac, M.D., Ph.D. Cardiac ... Show more areas of focus for Anca Chiriac, M.D., Ph. ... Heart failure, Amyloidosis, Myocarditis, Pericarditis, Vasculitis, ...

  3. Cardiovascular Medicine - Doctors - Mayo Clinic

    Anca Chiriac, M.D., Ph.D. Cardiac Electrophysiologist. Jacksonville, FL. Areas of focus: Pacemaker insertion, Implantable cardioverter ...

  4. https://www.mayoclinic.org/~/media/0439A7376021433E8FB3180F95C8FF95

  5. Publications - Rekha Mankad, M.D. - Mayo Clinic

    Mankad , R., Grogan , M.. Diagnosis of Cardiac Amyloidosis: Clinical and echocardiographic Features Current Cardiovascular Imaging Reports. 2018; 11(32).

  6. Median arcuate ligament syndrome (MALS) - Diagnosis and treatment - Mayo Clinic

    Ultrasound of the abdomen. This test uses sound waves to see how blood is flowing through the blood vessels. It can show if the celiac artery is compressed, ...

  7. Peripheral Nerve Stimulation Therapy For Atrial Fibrillation - Mayo Clinic

    The purpose of this study is to determine and compare the safety and efficacy of transcutaneous afferent patterned stimulation (TAPS) and respiratory-gated ...

  8. Focus Areas - Molecular Neurotherapeutics - Mayo Clinic Research

    Mayo Clinic's Molecular Neurotherapeutics Lab explores neuroimmunology in Alzheimer's disease, microglia & extracellular vesicles, tau aggregation & more.

  9. Cardiovascular Medicine - Doctors - Mayo Clinic

    Anca Chiriac, M.D., Ph.D. Cardiac ... Heart failure, Amyloidosis, Myocarditis, Pericarditis, Vasculitis, Sarcoidosis ...

  10. NLA101 In Adults Receiving High Dose Chemotherapy For AML - Mayo Clinic

    Phase 2 open-label, multi-center, randomized, controlled, dose-finding study of safety and efficacy of NLA101 to reduce the rate of infections associated with ...